Targeting oxidant-dependent mechanisms that drive COPD and its co-morbidities [ 2015 - ]

Research Grant

Researchers: Prof Ross Vlahos (Principal investigator) ,  A/Pr Steven Bozinovski ,  Prof Gary Anderson

Brief description Chronic obstructive pulmonary disease (COPD) is a lung disease that is the 4th leading cause of death worldwide. There is currently no effective therapy to treat people with COPD, which costs the Australian community over $8.8 billion/year. Much of the disease burden and health care costs in COPD is associated with the management of its comorbidities (i.e other chronic medical conditions such as heart disease). This project will develop novel therapies to treat COPD and its comorbidities.

Funding Amount $718,134.00

Funding Scheme Project Grants

Notes Standard Project Grant